April 12, 2023 10:36 AM EDT
News Briefing

Treg play­er Gen­tiBio turns to lay­offs; Cen­tu­ry Ther­a­peu­tics CEO de­parts

Kyle LaHucik

Senior Reporter

Treg biotech Gen­tiBio re­cent­ly en­act­ed lay­offs a lit­tle more than six months af­ter lin­ing up a pact with Bris­tol My­ers Squibb that could bal­loon …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times